A considerable body of evidence suggests that formation of potent reactive oxygen species and resulting oxidative/nitrative stress play a major role in acute and chronic inflammation and pain. Much of the knowledge in this field has been gathered by the use of pharmacological and genetic approaches. In this mini review, we will evaluate recent advances made towards understanding the roles of reactive oxygen species in inflammation, focusing in particular on superoxide and peroxynitrite. Given the limited space to cover this broad topic, here we will refer the reader to comprehensive review articles whenever possible.
Superoxide
Superoxide is formed from various sources, including normal cellular respiration, activated polymorphonuclear leucocytes, endothelial cells and mitochondrial electron flux [1, 2] . It is now well appreciated that, under physiological circumstances, the biological reactivity of superoxide is tightly controlled by SOD (superoxide dismutase) enzymes. These include the manganese-complexed enzyme in mitochondria (MnSOD) and the copper/zinc-complexed enzyme (CuZnSOD) present in the cytosol and extracellular surfaces [3] . During acute and chronic inflammations, superoxide is produced at rates that overwhelm the capacity of the endogenous SOD enzyme defence system to remove it, resulting in superoxide-mediated injury [4, 5] . Important proinflammatory roles for superoxide include: (i) endothelial cell damage and increased microvascular permeability [6, 7] ; (ii) up-regulation of adhesion molecules such as ICAM-1 (intercellular adhesion molecule 1) and P-selectin (through mechanisms not yet defined) that recruit neutrophils to sites of inflammation [8, 9] ; (iii) autocatalytic destruction of neurotransmitters and hormones such as noradrenaline (norepinephrine) and adrenaline (epinephrine) respectively [10] ; (iv) lipid peroxidation and oxidation; (v) DNA damage [11] ; and (vi) activation of PARP [poly(ADP-ribose) polymerase] [12] . PARP activation in particular is important in inflammation and is a target for therapeutic intervention; inhibitors of PARP activation such as nicotinamide and 3-aminobenzamide attenuate both acute and chronic inflammatory processes [12] . Superoxide also activates redoxsensitive transcription factors including NF-κB (nuclear factor κB) and AP-1 (activator protein 1) that in turn regulate genes encoding various pro-inflammatory and pro-nociceptive cytokines [9, [13] [14] [15] [16] [17] . In addition, superoxide interacts with and destroys the biological activity of nitric oxide [18] (Figure 1) . Importantly, the rate of interaction between superoxide and nitric oxide is faster than the rate of removal of superoxide by SOD [19] . As a consequence, important anti-inflammatory and tissue-protective properties of nitric oxide may be attenuated, notably maintenance of blood vessel tone, inhibition of platelet adhesion/aggregation and cytoprotection in numerous organs (including heart, intestine and kidney) [20] . Nitric oxide is known to mediate several of its beneficial effects through the activation of cyclooxygenase and subsequent release of beneficial and antiinflammatory prostaglandins [21, 22] . By interacting with superoxide, nitric oxide loses its ability to activate this enzyme.
Taken together, it is therefore not surprising that removal of superoxide by exogenous administration of SOD has been shown to be beneficial in a broad range of inflammatory diseases, both preclinically and clinically [5, [23] [24] [25] [26] . In addition, the native SOD enzyme attenuates intestinal injury induced by alcohol [27] , Helicobacter pylori [28] and nonsteroidal anti-inflammatory drugs including indomethacin, diclofenac and flurbiprofen [29] . When tested in humans in various clinical trials, bovine CuZnSOD (Orgotein R )
showed promising anti-inflammatory effects under acute and chronic conditions including rheumatoid arthritis, osteoarthritis as well as the deleterious side effects associated with chemotherapy and radiation therapy [24] . Thus the use of the native enzyme in clinical trials supports the concept that removal of superoxide is beneficial. However, there were drawbacks associated with its use, primarily the nonhuman origin of the bovine enzyme. This inevitably led to immunological reactions causing its removal from the market, except in Spain where it is still clinically used to prevent radiation-induced side effects [24] . Based on the concept that removal of superoxide modulates the course of inflammation, several low-molecular-mass [24, [30] [31] [32] [33] (Figure 2 ). Of these, M40403 advanced to Phase II clinical studies in the U.S.A. [34] . Numerous preclinical studies have shown these low-molecular-mass antioxidants to be potently antiinflammatory in animal models of tissue injury and acute/ chronic inflammation [5, 24, 35] . In addition, recent results have demonstrated that removal of superoxide and superoxide-derived reactive species is an attractive strategy to inhibit peripheral and central sensitization associated with several pain states. Thus these agents as well as other antioxidants have been reported to be effective against acute inflammatory pain [36, 37] , glutamate-induced hyperalgesia [38] , neuropathic pain [39] [40] [41] [42] [43] [44] , trigeminal pain, fibromyalgia and temporomandibular joint dysfunction [45, 46] , chronic pancreatitis [47] , post-irradiation of breast cancer fibrosis [48] and morphine-induced hyperalgesia and associated anti-nociceptive tolerance [49, 50] .
Peroxynitrite and oxidative/nitrative stress
Besides destroying the biological activity of nitric oxide (a key anti-inflammatory and cytoprotective agent), a fundamental consequence of the interaction between superoxide and nitric oxide is in situ formation of peroxynitrite [51] , a potent cytotoxic and pro-inflammatory molecule [12, [52] [53] [54] [55] (Figure 3 ). Thus removal of peroxynitrite by agents such as FeTMPS [5,10,15,20- [57] [58] [59] or WW85 [60] results in cytoprotective and anti-inflammatory effects. Although the actions of peroxynitrite in inflammation are numerous, a mechanism that is receiving greatest attention is its ability to nitrate protein tyrosine groups that modify the functional activity of key proteins [61] (Figure 3) .
At least two well-described pathways can lead to such protein nitration, one involving peroxynitrite [51] and the other utilizing H 2 O 2 and myeloperoxidase [62] . Involvement of these pathways in a particular pathophysiological setting can be dissected pharmacologically with agents that remove superoxide or nitric oxide, thereby preventing the formation of peroxynitrite and peroxynitrite-mediated protein nitration [36, 38, 63, 64] . Interestingly, these agents do not inhibit nitration driven by reactions other than peroxynitrite and thus are useful pharmacological tools to explore the pathophysiological consequences of peroxynitritedriven nitration. Biologic nitration of tyrosine to form 3-nitrotyrosine is associated with numerous diseases including transplant rejection, lung infection, central nervous system and ocular inflammations, septic shock, cancer and neurological disorders [ALS (amyotrophic lateral sclerosis), stroke, Parkinson's disease] [19] . Recently, our groups linked nitration and inactivation of MnSOD to the development of peripheral and central pain sensitization [36, 38] . Proteins typically are composed of 4% tyrosine residues although chemical nitration of isolated proteins modifies only a subset of these. The basis for this selectivity is not fully understood [61, 65] . Although there is no clearly defined mechanism of removal of this modification, there is evidence that such a signal could be turned off by either protein degradation or denitration. With respect to the latter, a specific activity termed denitrase, that removes the nitro group without degrading the protein, has been shown to occur in tissues [66] . Identification of the molecular basis for such an activity awaits further study. The advent of proteomics and the development of numerous immunological and analytical methodologies have revealed that tyrosine nitration is limited to specific proteins [61] . Nitration can be focused on specific tyrosine residues on proteins and potentially result in modification, loss or gain of function [67] [68] [69] . A key example of lost enzyme activity due to nitration in vivo is mitochondrial MnSOD, the enzyme that normally keeps concentrations of superoxide under tight control [3] . This protein is nitrated by peroxynitrite on Tyr-34 by an Mn-catalysed process that leads to enzyme inactivation [70] . The importance of MnSOD nitration/inactivation is highlighted by an overwhelming body of evidence linking nitration of this enzyme to diseases driven by overt production of peroxynitrite. These include ischaemia and reperfusion injury, organ transplantation, shock and inflammation, neurodegeneration in Alzheimer's disease, ALS or AIDS dementia complex [71] [72] [73] and pain [36, 38] .
Nitration and inactivation of mitochondrial MnSOD favour the accumulation of peroxynitrite [65] , which then nitrates and alters additional proteins and receptors perpetuating and extending the initial damage. For example, nitration of the mitochondrial proteins aconitase, cytochrome c, voltage-dependent anion channel, ATPase and succinyl-CoA oxoacid-CoA transferase [65, 74] disrupts mitochondrial metabolism. Such a mitochondrial injury in turn triggers apoptotic signalling of cell death. Importantly, the enhanced peroxidative activity of nitrated cytochrome c [65, 67] may further contribute to oxidative damage. Mitochondrial dysfunction is thought to represent an important component of various cardiovascular [75] and neurological disorders [76] [77] [78] as well as neuropathic pain states [79] .
Other important consequences of protein tyrosine nitration are being evaluated in various settings. For example, glutamate transporters and glutamine synthase play a central role in regulating the homoeostasis of extracellular glutamate and its metabolic fate. These proteins are also nitrated by peroxynitrite [80] [81] [82] [83] [84] . Nitration of glutamate transporters by peroxynitrite inhibits their ability to transport glutamate from the synaptic cleft to the neurons where it is then metabolized to non-toxic glutamine by glutamine synthase [85] . Nitration of the active site tyrosine residue (Tyr-160) on glutamine synthase by peroxynitrite destroys its enzymatic activity [82] [83] [84] . As a consequence, excitotoxic and neurotoxic glutamate accumulates in the synaptic cleft where it is not metabolized, and within neurons, thereby leading to neurotoxicity. In addition, peroxynitrite nitrates tyrosine residues present on the NMDA receptor subunits, an event leading to constant potentiation of synaptic currents, calcium influx and ultimately neuronal excitotoxicity [86] [87] [88] . Therefore optimal glutamatergic transmission can be compromised by nitration, potentially contributing to the severity of stroke, spinal cord injury, neuropathic pain and opiateinduced hyperalgesia and tolerance all of which are known to be impacted by the excessive presence of glutamate [89] [90] [91] [92] [93] [94] [95] [96] [97] Functional alteration of proteins through nitration can also have a significant impact in cardiovascular diseases. In particular we now know that the endothelial enzyme prostacyclin synthase is nitrated by peroxynitrite at haemadjacent Tyr-430 in a process catalysed by the active site haem-thiolate involving transient ferryl species [98, 99] . Importantly, this enzyme co-localizes with the endothelial form of nitric oxide synthase in the caveolae, which may accentuate it as a sensitive and critical target of peroxynitrite. Recent experiments indicate that inflammation of arterial walls during atherosclerosis results in rapid prostacyclin synthase nitration by a peroxynitrite-dependent mechanism [99] . Prostacyclin, the product of this enzyme, is a powerful anti-thrombotic and vasodilatory mediator that is known to also limit vascular remodelling and cholesterol uptake [100, 101] . Thus nitration of prostacyclin synthase by peroxynitrite reduces local prostacyclin while leaving concentrations of thromboxane A 2 , a potent pro-thrombotic and vasoconstricting mediator also known to promote vascular remodelling [100, 101] , relatively unaffected. Thus peroxynitrite nitration of prostacyclin synthase removes a protective constraint on thrombogenesis, hypertension and atherogenesis, by favouring accumulation of thromboxane A 2 [102] . The risk of thrombotic events in cardiovascular disorders could therefore be increased as a consequence of peroxynitrite-mediated protein nitration.
Clearly, examples of this nature will grow as we begin to unravel, understand and appreciate the impact that protein nitration has in pathophysiological conditions.
Conclusions and prospectus
Superoxide and peroxynitrite play fundamental roles in inflammation that makes them critical for the development of novel anti-inflammatory agents. Protein tyrosine nitration is gaining considerable interest in biomedical research, because it can alter protein function, is associated with acute and chronic disease states and can be a predictor of disease risk. A comprehensive and focused approach, utilizing proteomics, biochemical, pharmacological and genetic strategies to understand the functional relevance of protein tyrosine nitration, will identify novel targets that are pivotal to the management of human diseases.
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